Eden Research Share Discussion Threads

[kittybiscuits] 24/1/2024 23:17

Says the man who posts a few times a day every day for years and lies in every single post

[supersonico] 24/1/2024 18:51

Eden slide shows potential US Insecticide sales in 2024/25 AND 2025/26 for EU.

Lets look at the 2024 growing season Ecovelex announcement timeline for reference and perspective on what might be ahead for the Insecticide RNS trail.

We should also bear in mind that the 2024 date was fixed in 2021 and imo some of the major partners / Whales are in place already...the table places have been mostly set imo thats why Abrey flips between 'partners' and 'potential partners' ... and it's a 'global deal' where distributors in China and India are in play....again all imo...or as Abrey likes to say.. "it could be it's a global deal or a regional or even country by country ..it remains to be seen "

12th May 2021 Milestone Agreement signed with Corteva
30th May 2023 Eden and Corteva seek to bring Ecovelex to market.
3rd Jul 2023 Regulatory Application for Ecovelex in the UK
16th Aug 2023 First Order For Ecovelex
18th Dec 2023 Ecovelex 2023 Approval in Italy

So as things stand May looks like a good month for big announcements and provides time for those 'financial professionals' able to pay $1000 door / access prices gathering in New Jersey and London an opportunity to fill their boots..

AWGATWT

[chrischas] 24/1/2024 18:21

Interesting comment:"Eden has started to see results from its potential partners come in and we are pleased to say that they are, thus far, in line with our own results.

[supersonico] 24/1/2024 17:42

Annual Eden Insecticide / development update...2019- Jan 2024

15 January 2019;
The opportunities in Eden's core crop protection business are growing well. In addition to the products that Eden has developed and is commercialising through its partners, there are a number of pipeline products which are in the process of being tested by potential partners including several candidate insecticide products which would represent our first entry into the insecticide segment. Whilst it is early in the development of these formulations, initial results have been encouraging.


14 January 2020
Looking forward, we expect to be able to announce further marketing authorisations for both Mevalone and Cedroz as well as progress that is being made with existing and new partners in areas such as seed treatments, insecticides and other applications where the use of our active ingredients and Sustaineä encapsulation technology can bring important benefits to our commercial partners, growers, and ultimately consumers who benefit from sustainable agriculture."

11 February 2021
Development work continued largely as hoped during 2020, including on Eden's insecticide and seed treatment products. In addition, the Company continues to work with a number of parties to develop products that avoid polymer encapsulation using Eden's proprietary Sustaine® technology with third party active ingredients.

2nd March 2022
Development of Eden's seed treatment and insecticide products continues on track with good progress made in 2021 and the Corteva partnership has moved into the next stage of development triggering a milestone payment to Eden.


10 January 2023
Field trials in 2021 and 2022 have produced encouraging results for our insecticide candidates. The Company is pleased to be in position where it has now agreed on a final formulation, entered into testing agreements and sent trial-scale samples to multiple interested parties who are undertaking their own trial work.

Eden has started to see results from its potential partners come in and we are pleased to say that they are, thus far, in line with our own results.
The Company expects there to be a high level of interest for this product, particularly in the key markets of Europe and the US.

22 January 2024
A number of potential commercial partners for Eden's insecticide product ran, between them, a large number of field trials in 2023 and, so far, these have produced encouraging results.

Eden has started to see results from its potential partners come in and we are pleased to say that they are, thus far, in line with our own results.
The Company expects there to be a high level of interest for this product, particularly in the key markets of Europe and the US.

Eden has now started commercial discussions with various potential partners to begin the evaluation of who to appoint as distribution partner for the insecticide product and shall update the market during 2024, as appropriate.
................................................

30 November 2023

Abrey commentary from ..Presentation from the November 30 Small Cap Growth Virtual Investor Conference

"We have undertaken a large number of field trials ourselves, this year we had Partners ..potential partners undertaking their own trials in excess of 140 in total spread across the potential partners so we hope and expect by the end of this year to have all the results from those various trials that have been undertaken and early indications are positive.

We will then move into commercial negotiations with those potential partners ..we would look to do distribution agreements with some or maybe one or all of those potential partners and it could be it's a global deal or a regional or even country by country ..it remains to be seen and depends on the business cases put forward to us ..but this one we're really excited about ..it's a big opportunity ..there is a dearth of Bio-insecticides available which is why we have seen so much interest for this product ..in terms of the actual opportunity again this is a big one for us potentially around $35-$40m per annum at peak".

(Eden Research plc (OTCQB: EDNSF | AIM: EDEN): Virtual Investor Conferences /

[timbo_slice] 24/1/2024 13:54

@MoronPOV it's not me. You've got the wrong person.

[neutralpov] 24/1/2024 12:07

STFU, Timbo_Slice. Punishment for your frauds looms.

And ROTFL, the two of them are in overdrive, simulating dozens if not hundreds of ""investors"".

EDEN.L Restated target share price ... ZERO PENCE (0.000p)

[money never sleeps] 24/1/2024 09:35

Neuts is oh so quiet now results are out. It speaks volumes. Trust no-one.

[supersonico] 23/1/2024 18:24

900,000 @ 6.3p delayed trade.

supersonico - 22 Jan 2024 - 14:56:02 - 16579 of 16616 Eden Research - EDEN
Given Eden's recent US facing PR and the associated wish to attract US institutions does anyone expect Eden and Cavendish to be anything other than ultra Conservative while insiders load up?

[monet] 23/1/2024 18:00

Neut(Always wondered what it must be like to be stupid)
Just look in the mirror 😂😂

[money never sleeps] 23/1/2024 17:46

I am almost certain that it will be Neuts

[weyweyumfozo] 23/1/2024 17:27

900,000 @ 6.3p delayed trade.

[neutralpov] 23/1/2024 16:04

Always wondered what it must be like to be stupid.

{chortle)

[monet] 23/1/2024 12:19

Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,Neuts OBSESSION with EDEN 24/7,

[alchemy] 23/1/2024 12:17

Might go quiet this time next year.My views not to affect the SP!Revenue to at least double 2024 to 6 or more Margin 40% or better Expenditure to go up because of temptation.Very near or at break even.Visibility of runaway success increased lots

[timbo_slice] 23/1/2024 11:11

Lol, Neuts such poor research.

[neutralpov] 23/1/2024 10:56

Above, just cut and paste from eleven years ago in this same DB, a few nouns changed. Very poor quality of paid ramping p!mp (with 38 IDs identified so far).

As to the brown-noser who's so keen for a pat on the head from the boardies, thanks for confirming that:
money never sleeps
northwick
kittybiscuits
timbo_slice
etc.
are all one and the same desperate trapped bull, who rushed in 15 yrs ago without thought of how to get out, then kept topping up ("can't help it, bit like the less legal hobby of yours)......
.....but honest, no confirmation was needed, we knew it already. You'll have plenty of time while detained at Charlie Boy's Pleasure asking yourself how you could have been so stooooooooooooooooooooooooooopid as to miss the big hole in any defence you might be so foolish as to advance, instead of pleading guilty.

PCOJ too? Your only comfort will be the knowledge that the paid ramper (who sneers at your utter gullibility) will be banged up for even longer. His employer, alas, probably - the criminal standard is higher 0 can't be done with a reasonable prospect of success. Shrugs.

Now ferkorf, I've indulged you enough.

[monet] 23/1/2024 08:02

From the mail online

Eden Research, the biopesticide producer, expects its revenues to have increased by nearly three-quarters to £3.1million in 2023.

And it is likely to have racked up an annual loss of £1.2million, lower than the £1.9million pencilled in by analysts. Shares added 4.9 per cent, or 0.28p, to 5.9p.

[...]

[investingisatrickygame] 23/1/2024 08:02

Super,

yes, it was the ShareSoc event.

So two events we know of. Hopefully Eden will now reframe their messaging and add reasons to invest in Eden, such that investors choose to place their $'s and £'s in Eden rather than elsewhere.

Certainly, there are enough triggers to now do so with one remaining major announcement that we have been primed for, that being the insecticide and thereafter, it should be easy for investors to understand that the primary activities to expect will be label extensions and new regulatory submissions and permissions.

To support that end aim, a nice data table, effectively an update of the Appendix in this RNS from 2020, would be useful, but adding 2 additional columns.

Alongside 'estimated market side' (addressable market) add a column that shows anticipated market share and one further column that shows the remaining period of regulatory approval. Historically, Eden has already shown market share anticipated on their website for one product and the regulatory approval period would be very helpful to see in one central place for all territories, by product, as it will already be in the public domain anyway.

This will allow investors to calculate total potential continuous income in the eyes of the Company and therefore start to understand the potential value and future value of the Company. It is only a steer and not exact, but a guide is better than flying blind and will support decisions to further invest or/and invest for the first time.

'Build it and they will come' might be an apt phrase with our insecticide and the 10 or 11 partners that have evaluated it, but it also applies to Eden's shareholders. Build the investment story and they will come. That's what we need to do, don't we, to help get the share price up to where it should be.


Here's another one for those old enough. 'I liked the shaver so much, I bought the company'. The way Eden is building, someone too might like Eden very much. That's why the share price needs to represent proper value at all times.

[supersonico] 23/1/2024 07:01

Additionally,

I think this the Feb PR event that you were referring to.

ShareSoc Growth Company Live Seminar, London – 28 Feb 2024, 4:30pm

Featuring: Itaconix PLC (ITX), Quartix Technologies plc (QTX) and Eden Research PLC (EDEN), Bioventix plc (BVXP)

[supersonico] 23/1/2024 06:48

Investing,

Further to your question yesterday re my assertion that Eden are seeking to raise awareness amongst US Institutional Investors ..

Skyline Signature Series: Eden Research PLC
Event by Skyline Corporate Communications Group, LLC
Thu, Nov 9, 2023

'The Skyline Signature Series is a proprietary branded live webinar event that provides public companies with a convenient and effective forum to communicate their story to a diverse audience of financial professionals through live CEO virtual presentations'.

[money never sleeps] 23/1/2024 02:47

I'm worried about you though, Neuts.

What if you are wrong..... What if your accusations of lies and deceit land you in hot water?

Is it ok for someone to make unfounded, baseless accusations?

Will the judge chuck the book at you instead?

[money never sleeps] 23/1/2024 02:42

Oh, and Neuts

Did you see the news today?

Eden product sales revenue has increased.

AGAIN.

Whatever next !!

[money never sleeps] 23/1/2024 02:40

Hi Neuts!

It is very late for you to be up.

Please can you let me have a reference for those provisions?

There's a good chap